EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSAMXG00000025266
Gene Symbol: ADRA2C
2 Cross references
156 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSAMXG00000025208
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSAMXG00000026034
Gene Symbol: ADRB2
3 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSAMXG00000035685
Gene Symbol: AKR1B1
3 Cross references
346 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSAMXG00000007652
Gene Symbol: AKR1B1.1
1 Cross references
346 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSAMXG00000030901
Gene Symbol: AKR1B1.1
1 Cross references
346 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSAMXG00000036078
Gene Symbol: AKR1B1.2
1 Cross references
347 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSAMXG00000042395
Gene Symbol: LOC103035023
3 Cross references
346 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSAMXG00000036841
Gene Symbol: LOC103035339
3 Cross references
347 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSAMXG00000034098
Gene Symbol: LOC103040561
3 Cross references
346 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSAMXG00000031791
Gene Symbol: GAA
4 Cross references
233 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSAMXG00000030491
Gene Symbol: LOC103024013
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).